{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:33:43Z","timestamp":1770730423592,"version":"3.49.0"},"reference-count":219,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundo Europeu de Desenvolvimento Regional (FEDER)","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]},{"name":"CHAIR in Onco-Innovation from Faculty of Medicine, University of Porto","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Drug repurposing aims to identify new therapeutic uses for drugs that have already been approved for other conditions. This approach can save time and resources compared to traditional drug development, as the safety and efficacy of the repurposed drug have already been established. In the context of cancer, drug repurposing can lead to the discovery of new treatments that can target specific cancer cell lines and improve patient outcomes. Vasodilators are a class of drugs that have been shown to have the potential to influence various types of cancer. These medications work by relaxing the smooth muscle of blood vessels, increasing blood flow to tumors, and improving the delivery of chemotherapy drugs. Additionally, vasodilators have been found to have antiproliferative and proapoptotic effects on cancer cells, making them a promising target for drug repurposing. Research on vasodilators for cancer treatment has already shown promising results in preclinical and clinical studies. However, additionally research is needed to fully understand the mechanisms of action of vasodilators in cancer and determine the optimal dosing and combination therapy for patients. In this review, we aim to explore the molecular mechanisms of action of vasodilators in cancer cell lines and the current state of research on their repurposing as a treatment option. With the goal of minimizing the effort and resources required for traditional drug development, we hope to shed light on the potential of vasodilators as a viable therapeutic strategy for cancer patients.<\/jats:p>","DOI":"10.3390\/cells12040671","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T05:27:01Z","timestamp":1676870821000},"page":"671","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["In Vitro Drug Repurposing: Focus on Vasodilators"],"prefix":"10.3390","volume":"12","author":[{"given":"Eduarda","family":"Ribeiro","sequence":"first","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-5874","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Costa","sequence":"additional","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"}]},{"given":"Francisco","family":"Vasques-N\u00f3voa","sequence":"additional","affiliation":[{"name":"Cardiovascular R&D Center, Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1283-1042","authenticated-orcid":false,"given":"Nuno","family":"Vale","sequence":"additional","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0895-7061(99)00059-X","article-title":"Fenoldopam: A new parenteral antihypertensive: Consensus roundtable on the management of perioperative hypertension and hypertensive crises","volume":"12","author":"Oparil","year":"1999","journal-title":"Am. J. Hypertens."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1527-3466.1990.tb00437.x","article-title":"Vasodilator Therapy in Hypertension","volume":"8","year":"1990","journal-title":"Cardiovasc. Drug Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Na Takuathung, M., Sakuludomkan, W., Khatsri, R., Dukaew, N., Kraivisitkul, N., Ahmadmusa, B., Mahakkanukrauh, C., Wangthaweesap, K., Onin, J., and Srichai, S. (2022). Adverse Effects of Angiotensin-Converting Enzyme Inhibitors in Humans: A Systematic Review and Meta-Analysis of 378 Randomized Controlled Trials. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19148373"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.20517\/2574-1209.2021.63","article-title":"Contemporary pharmacological treatment strategies for patients with angina and unobstructed coronary arteries (ANOCA) due to coronary microvascular dysfunction","volume":"5","author":"McChord","year":"2021","journal-title":"Vessel Plus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-Converting Enzyme Inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.hlc.2017.06.721","article-title":"Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials","volume":"27","author":"Tsoi","year":"2018","journal-title":"Heart Lung Circ."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium Channel Blockers","volume":"13","author":"Elliott","year":"2011","journal-title":"J. Clin. Hypertens."},{"key":"ref_8","first-page":"28S","article-title":"Pharmacology and mechanisms of action of calcium-channel blockers","volume":"2","author":"Katz","year":"1986","journal-title":"J. Clin. Hypertens."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00129784-200707001-00003","article-title":"Calcium channel blockers: Differences between subclasses","volume":"7","author":"Frishman","year":"2007","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2018.12.008","article-title":"Anti-anginal drugs: Systematic review and clinical implications","volume":"283","author":"Pavasini","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e13152","DOI":"10.1097\/MD.0000000000013152","article-title":"Blood pressure lowering effect of calcium channel blockers on perioperative hypertension: A systematic review and meta-analysis","volume":"97","author":"Lin","year":"2018","journal-title":"Medicine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1524-6175.2001.00455.x","article-title":"Direct Vasodilators and their Role in Hypertension Management: Minoxidil","volume":"3","author":"Sica","year":"2001","journal-title":"J. Clin. Hypertens."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.15420\/ecr.2018.9.2","article-title":"Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris","volume":"13","author":"Tarkin","year":"2018","journal-title":"Eur. Cardiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"B4","DOI":"10.1016\/0002-9149(92)90588-P","article-title":"Biochemical mechanism of organic nitrate action","volume":"70","author":"Fung","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina","volume":"281","author":"Heidenreich","year":"1999","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1161\/01.CIR.0000094403.78467.C3","article-title":"Physiology and pathophysiology of vascular signaling controlled by guanosine 3\u2032,5\u2032-cyclic monophosphate-dependent protein kinase [corrected]","volume":"108","author":"Feil","year":"2003","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijcard.2004.12.012","article-title":"Calcium sensitizer agents: A new class of inotropic agents in the treatment of decompensated heart failure","volume":"103","author":"Perrone","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"ref_19","first-page":"407","article-title":"Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction","volume":"38","author":"Huang","year":"2013","journal-title":"J. Formul. Manag."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Duarte, D., R\u00eama, A., Amorim, I., and Vale, N. (2022). Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells. Biomolecules, 12.","DOI":"10.3390\/biom12020190"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40545-020-00282-8","article-title":"Repurposing existing drugs for new uses: A cohort study of the frequency of FDA-granted new indication exclusivities since 1997","volume":"14","author":"Sahragardjoonegani","year":"2021","journal-title":"J. Pharm. Policy Pract."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/covid2020011","article-title":"A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19","volume":"2","author":"Khataniar","year":"2022","journal-title":"COVID"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/17425255.2017.1389897","article-title":"In silico ADME-Tox modeling: Progress and prospects","volume":"13","author":"Alqahtani","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2174\/1386207325666220105150147","article-title":"In Silico Trial Approach for Biomedical Products: A Regulatory Perspective","volume":"25","author":"Jose","year":"2022","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003495-198631030-00002","article-title":"Enalapril","volume":"31","author":"Todd","year":"1986","journal-title":"Drugs"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/02841860310022346","article-title":"Angiotensin converting enzyme inhibitors for cancer treatment?","volume":"43","author":"Lindberg","year":"2004","journal-title":"Acta Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature03094","article-title":"G1 cell-cycle control and cancer","volume":"432","year":"2004","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41419-020-2675-x","article-title":"Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-\u03baB\/STAT3-regulated proteins","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_30","first-page":"318","article-title":"The Angiotensin-Converting Enzyme Inhibitor \u2018Enalapril\u2019 Increases the Anti-Proliferative Activity of 5-Fluorouracil in Colorectal Cancer Cells","volume":"5","author":"Mostafapour","year":"2021","journal-title":"Eurasian J. Med. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"ref_32","first-page":"2885","article-title":"Enalapril-induced apoptosis of acute promyelocytic leukaemia cells involves STAT5A","volume":"32","author":"Purclutepe","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1006233521325","article-title":"Mechanism of captopril toxicity to a human mammary ductal carcinoma cell line in the presence of copper","volume":"55","author":"Small","year":"1999","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0009-8981(90)90260-Y","article-title":"Influence of angiotensin converting enzyme inhibitor (captopril) on kidney epithelial cells in vitro: Studies on potassium (86Rb) influx and cellular proliferation","volume":"187","author":"Bauer","year":"1990","journal-title":"Clin. Chim. Acta"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3181\/00379727-196-43189","article-title":"Angiotensin-converting enzyme inhibition reduces neuroblastoma cell growth rate","volume":"196","author":"Chen","year":"1991","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3181\/00379727-205-43681","article-title":"Captopril inhibits proliferation of human lung fibroblasts in culture: A potential antifibrotic mechanism","volume":"205","author":"Nguyen","year":"1994","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3181\/00379727-210-43942","article-title":"Inhibitors of Angiotensin-Converting Enzyme Modulate Mitosis and Gene Expression in Pancreatic Cancer Cells","volume":"210","author":"Reddy","year":"1995","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_38","first-page":"1967","article-title":"Anti-cancer Potential of Captopril and Botulinum Toxin Type-A and Associated p53 Gene Apototic Stimulating Activity","volume":"18","author":"Shebl","year":"2019","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","article-title":"Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer","volume":"37","author":"Shen","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Riddiough, G.E., Fifis, T., Walsh, K.A., Muralidharan, V., Christophi, C., Tran, B.M., Vincan, E., and Perini, M.V. (2021). Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Features of Tumor Invasion and Down-Regulates C-Myc Expression in a Mouse Model of Colorectal Cancer Liver Metastasis. Cancers, 13.","DOI":"10.3390\/cancers13112734"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1021\/acsabm.2c00486","article-title":"Cancer-Associated Fibroblast-Targeted Delivery of Captopril to Overcome Penetration Obstacles for Enhanced Pancreatic Cancer Therapy","volume":"5","author":"Chen","year":"2022","journal-title":"ACS Appl. Bio. Mater."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"106771","DOI":"10.1016\/j.clineuro.2021.106771","article-title":"Captopril inhibits Matrix Metalloproteinase-2 and extends survival as a temozolomide adjuvant in an intracranial gliosarcoma model","volume":"207","author":"Pinheiro","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ki.2009.346","article-title":"Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy","volume":"76","author":"Tan","year":"2009","journal-title":"Kidney Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2002-01-0075","article-title":"Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells","volume":"101","author":"Sarfati","year":"2003","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.brainres.2008.06.122","article-title":"PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model","volume":"1230","author":"Black","year":"2008","journal-title":"Brain Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"18202","DOI":"10.1073\/pnas.1006965107","article-title":"Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction","volume":"107","author":"Das","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-010-0765-7","article-title":"Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells","volume":"124","author":"Di","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1007\/s11095-014-1347-x","article-title":"Co-delivery of Sildenafil (Viagra\u00ae) and Crizotinib for synergistic and improved anti-tumoral therapy","volume":"31","author":"Marques","year":"2014","journal-title":"Pharm. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ejpb.2014.09.013","article-title":"Combinatorial delivery of Crizotinib-Palbociclib-Sildenafil using TPGS-PLA micelles for improved cancer treatment","volume":"88","author":"Gaspar","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1124\/mol.113.090043","article-title":"Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal\/genitourinary cancer cells","volume":"85","author":"Booth","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"99451","DOI":"10.18632\/oncotarget.19807","article-title":"Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen\/ nitrogen species","volume":"8","author":"Roberts","year":"2017","journal-title":"Oncotarget"},{"key":"ref_52","first-page":"3311","article-title":"Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo","volume":"5","author":"Mei","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1568009622666220816114543","article-title":"Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-\u03b21\/Smad2\/3 Pathway","volume":"23","author":"Liu","year":"2023","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jpp\/rgab049","article-title":"Repurposing of sildenafil as antitumour; induction of cyclic guanosine monophosphate\/protein kinase G pathway, caspase-dependent apoptosis and pivotal reduction of Nuclear factor kappa light chain enhancer of activated B cells in lung cancer","volume":"73","author":"AboYoussef","year":"2021","journal-title":"J. Pharm. Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Urla, C., Stagno, M.J., Fuchs, J., Warmann, S.W., and Schmid, E. (2022). Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma. J. Cancer Res. Clin. Oncol.","DOI":"10.1007\/s00432-022-04092-0"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/dna.2020.6467","article-title":"Tadalafil Reverses the Effect of Three-Dimensional Cell Culture System on Stem Cell Features in A549 and SK-MES-1","volume":"40","author":"Li","year":"2021","journal-title":"DNA Cell Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2147\/TCRM.S3336","article-title":"Tadalafil in the treatment of erectile dysfunction","volume":"4","author":"Coward","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/j.febslet.2013.07.041","article-title":"Phosphodiesterase 5 inhibitor acts as a potent agent sensitizing acute myeloid leukemia cells to 67-kDa laminin receptor-dependent apoptosis","volume":"587","author":"Kumazoe","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2016.05.010","article-title":"Phosphodiesterase 5\/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway","volume":"378","author":"Liu","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopha.2018.01.117","article-title":"Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2","volume":"99","author":"Ahmadian","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tiv.2018.01.009","article-title":"Azilsartan and its Zn(II) complex. Synthesis, anticancer mechanisms of action and binding to bovine serum albumin","volume":"48","author":"Aguirre","year":"2018","journal-title":"Toxicol. Vitr."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Alaaeldin, R., Ali, F.E.M., Bekhit, A.A., Zhao, Q.L., and Fathy, M. (2022). Inhibition of NF-kB\/IL-6\/JAK2\/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan. Molecules, 27.","DOI":"10.3390\/molecules27227825"},{"key":"ref_63","first-page":"863","article-title":"Inhibition of angiotensin II type 1 receptor by candesartan reduces tumor growth and ameliorates fibrosis in colorectal cancer","volume":"20","author":"Tabatabai","year":"2021","journal-title":"Excli. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"31413","DOI":"10.18632\/oncotarget.8920","article-title":"Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt\/\u03b2-catenin signaling","volume":"7","author":"Tong","year":"2016","journal-title":"Oncotarget"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7150\/jca.49641","article-title":"MUC 15 Promotes Osteosarcoma Cell Proliferation, Migration and Invasion through Livin, MMP-2\/MMP-9 and Wnt\/\u03b2-Catenin Signal Pathway","volume":"12","author":"Chen","year":"2021","journal-title":"J. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.yexcr.2018.04.022","article-title":"Antihypertensive drug-candesartan attenuates TRAIL resistance in human lung cancer via AMPK-mediated inhibition of autophagy flux","volume":"368","author":"Rasheduzzaman","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s13346-020-00842-0","article-title":"Candesartan treatment enhances liposome penetration and anti-tumor effect via depletion of tumor stroma and normalization of tumor vessel","volume":"11","author":"Cai","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"19943","DOI":"10.1038\/s41598-021-99412-8","article-title":"Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1\/CCR2 pathway","volume":"11","author":"Hachiya","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.21037\/atm-20-5293","article-title":"Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma","volume":"9","author":"Feng","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_70","first-page":"1893","article-title":"Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling","volume":"27","author":"Du","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1745-7270.2008.00402.x","article-title":"Angiotensin II suppresses adriamycin-induced apoptosis through activation of phosphatidylinositol 3-kinase\/Akt signaling in human breast cancer cells","volume":"40","author":"Zhao","year":"2008","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_72","first-page":"506","article-title":"Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer","volume":"20","author":"Hashemzehi","year":"2021","journal-title":"Excli. J."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Takagi, H., Kaji, K., Nishimura, N., Ishida, K., Ogawa, H., Takaya, H., Kawaratani, H., Moriya, K., Namisaki, T., and Akahane, T. (2021). The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. Cells, 10.","DOI":"10.3390\/cells10030575"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000445602","article-title":"Angiotensin II Enhances Proliferation and Inflammation through AT1\/PKC\/NF-\u03baB Signaling Pathway in Hepatocellular Carcinoma Cells","volume":"39","author":"Ji","year":"2016","journal-title":"Cell Physiol. Biochem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.toxlet.2018.05.036","article-title":"Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B","volume":"295","author":"Saber","year":"2018","journal-title":"Toxicol. Lett."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"938439","DOI":"10.3389\/fimmu.2022.938439","article-title":"Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13014-021-01775-9","article-title":"Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2\/neu-positive orthotopic breast cancer model","volume":"16","author":"Li","year":"2021","journal-title":"Radiat. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1073\/pnas.1818357116","article-title":"Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma","volume":"116","author":"Zhao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjp.0705339","article-title":"An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells","volume":"139","author":"Kurikawa","year":"2003","journal-title":"Br. J. Pharm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/00365521.2013.777776","article-title":"The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice","volume":"48","author":"Masamune","year":"2013","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1179\/1973947815Y.0000000055","article-title":"Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line","volume":"28","author":"Bakhtiari","year":"2016","journal-title":"J. Chemother."},{"key":"ref_82","first-page":"118","article-title":"Role of Caspases and Reactive Oxygen Species in Rose Bengal-Induced Toxicity in Melanoma Cells","volume":"10","author":"Mousavi","year":"2007","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"645460","DOI":"10.1155\/2012\/645460","article-title":"Drug-induced oxidative stress and toxicity","volume":"2012","author":"Deavall","year":"2012","journal-title":"J. Toxicol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.biopha.2017.06.074","article-title":"The role of ROS and NF-\u03baB pathway in olmesartan induced-toxicity in HeLa and mcf-7 cell lines","volume":"93","author":"Bakhtiari","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_85","first-page":"11","article-title":"Combinatorial effects of telmisartan and docetaxel on cell viability and metastatic gene expression in human prostate and breast cancer cells","volume":"11","author":"Khorsand","year":"2022","journal-title":"Mol. Biol. Res. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3892\/mmr.2020.11144","article-title":"Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro","volume":"22","author":"Kobara","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Koyama, N., Nishida, Y., Ishii, T., Yoshida, T., Furukawa, Y., and Narahara, H. (2014). Telmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0093050"},{"key":"ref_88","first-page":"193","article-title":"Telmisartan as a peroxisome proliferator-activated receptor-\u03b3 ligand is a new target in the treatment of human renal cell carcinoma","volume":"2","author":"Funao","year":"2009","journal-title":"Mol. Med. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3892\/ijo.2017.4177","article-title":"Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest","volume":"51","author":"Samukawa","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Matsui, T., Chiyo, T., Kobara, H., Fujihara, S., Fujita, K., Namima, D., Nakahara, M., Kobayashi, N., Nishiyama, N., and Yachida, T. (2019). Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133197"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1111\/jcmm.17259","article-title":"Telmisartan anti-cancer activities mechanism through targeting N-cadherin by mimicking ADH-1 function","volume":"26","author":"Khorsand","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ajco.13574","article-title":"Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation","volume":"18","author":"Wang","year":"2022","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/01635581.2019.1613552","article-title":"Telmisartan Influences the Antiproliferative Activity of Linoleic Acid in Human Colon Cancer Cells","volume":"72","author":"Chrzanowska","year":"2020","journal-title":"Nutr. Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.21873\/anticanres.15358","article-title":"Telmisartan Exerts Cytotoxicity in Scirrhous Gastric Cancer Cells by Inducing G0\/G1 Cell Cycle Arrest","volume":"41","author":"Tsujiya","year":"2021","journal-title":"Anticancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/CEJ.0b013e32832f9c00","article-title":"Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation","volume":"18","author":"Wang","year":"2009","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Lim, H., He, D., Qiu, Y., Krawczuk, P., Sun, X., and Xie, L. (2019). Rational discovery of dual-indication multi-target PDE\/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology. PLoS Comput. Biol., 15.","DOI":"10.1371\/journal.pcbi.1006619"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-016-0720-6","article-title":"Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women","volume":"18","author":"Wilson","year":"2016","journal-title":"Breast Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Lee, A.R., Seo, M.J., Kim, J., Lee, D.M., Kim, I.Y., Yoon, M.J., Hoon, H., and Choi, K.S. (2019). Lercanidipine Synergistically Enhances Bortezomib Cytotoxicity in Cancer Cells via Enhanced Endoplasmic Reticulum Stress and Mitochondrial Ca2+ Overload. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246112"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3892\/br.2022.1533","article-title":"Amlodipine inhibits proliferation, invasion, and colony formation of breast cancer cells","volume":"16","author":"Alqudah","year":"2022","journal-title":"Biomed. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"902305","DOI":"10.3389\/fphar.2022.902305","article-title":"Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer","volume":"13","author":"Fu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bcp.2006.12.011","article-title":"G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells","volume":"73","author":"Yoshida","year":"2007","journal-title":"Biochem. Pharm."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1245\/s10434-021-09645-0","article-title":"Amlodipine and Verapamil, Voltage-Gated Ca2+ Channel Inhibitors, Suppressed the Growth of Gastric Cancer Stem Cells","volume":"28","author":"Shiozaki","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"105152","DOI":"10.1016\/j.tiv.2021.105152","article-title":"Calcium channel blockers lercanidipine and amlodipine inhibit YY1\/ERK\/TGF-\u03b2 mediated transcription and sensitize the gastric cancer cells to doxorubicin","volume":"74","author":"Panneerpandian","year":"2021","journal-title":"Toxicol. Vitr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/CAD.0000000000001273","article-title":"Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer","volume":"33","author":"Karaman","year":"2022","journal-title":"Anticancer Drugs"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Chen, Y.-C., Chen, J.-H., Tsai, C.-F., Wu, C.-T., Wu, M.-H., Chang, P.-C., and Yeh, W.-L. (2021). Nicardipine Inhibits Breast Cancer Migration via Nrf2\/HO-1 Axis and Matrix Metalloproteinase-9 Regulation. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.710978"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1078-1439(02)00195-3","article-title":"TNP-470 combined with nicardipine suppresses in vivo growth of PC-3, a human prostate cancer cell line","volume":"7","author":"Arisawa","year":"2002","journal-title":"Urol. Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.18632\/aging.202539","article-title":"Nicardipine sensitizes temozolomide by inhibiting autophagy and promoting cell apoptosis in glioma stem cells","volume":"13","author":"Shi","year":"2021","journal-title":"Aging"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Braconi, C., Swenson, E., Kogure, T., Huang, N., and Patel, T. (2010). Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015195"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"13297","DOI":"10.1038\/ncomms13297","article-title":"L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling","volume":"7","author":"Jacquemet","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4161\/cam.5.5.17723","article-title":"Filopodia and adhesion in cancer cell motility","volume":"5","author":"Arjonen","year":"2011","journal-title":"Cell Adh. Migr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"108327","DOI":"10.1016\/j.celrep.2020.108327","article-title":"Calcium Channel Blocker Nifedipine Suppresses Colorectal Cancer Progression and Immune Escape by Preventing NFAT2 Nuclear Translocation","volume":"33","author":"Wu","year":"2020","journal-title":"Cell Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03160097","article-title":"Inhibition of cell growth and intracellular Ca2+ mobilization in human brain tumor cells by Ca2+ channel antagonists","volume":"22","author":"Lee","year":"1994","journal-title":"Mol. Chem. Neuropathol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"113695","DOI":"10.1016\/j.bcp.2019.113695","article-title":"Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment","volume":"171","author":"Chovancova","year":"2020","journal-title":"Biochem. Pharm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/bjc.1995.57","article-title":"Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells","volume":"71","author":"Kondo","year":"1995","journal-title":"Br. J. Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41389-022-00423-5","article-title":"Diltiazem inhibits breast cancer metastasis via mediating growth differentiation factor 15 and epithelial-mesenchymal transition","volume":"11","author":"Chen","year":"2022","journal-title":"Oncogenesis"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"BMT31","DOI":"10.2217\/bmt-2019-0018","article-title":"Diltiazem potentiation of doxorubicin cytotoxicity and cellular uptake in human breast cancer cells","volume":"8","author":"Damanhouri","year":"2019","journal-title":"Breast Cancer Manag."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2147\/CMAR.S228718","article-title":"Anticancer Effects of Antihypertensive L-Type Calcium Channel Blockers on Chemoresistant Lung Cancer Cells via Autophagy and Apoptosis","volume":"12","author":"Wong","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0959-8049(96)00045-7","article-title":"How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein","volume":"32","author":"Broxterman","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/bjc.1986.19","article-title":"Verapamil increases the sensitivity of primary human colorectal carcinoma tissue to vincristine","volume":"53","author":"Ince","year":"1986","journal-title":"Br. J. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/bjc.1986.18","article-title":"Resistance of human glioma to adriamycin in vitro: The role of membrane transport and its circumvention with verapamil","volume":"53","author":"Merry","year":"1986","journal-title":"Br. J. Cancer"},{"key":"ref_121","first-page":"63","article-title":"Verapamil enhances antitumor activity without increasing myeloid toxicity","volume":"101","author":"Morrow","year":"1987","journal-title":"Surgery"},{"key":"ref_122","first-page":"1967","article-title":"Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil","volume":"41","author":"Tsuruo","year":"1981","journal-title":"Cancer Res."},{"key":"ref_123","first-page":"1027","article-title":"Apoptosis of human primary and metastatic colon adenocarcinoma cell lines in vitro induced by 5-fluorouracil, verapamil, and hyperthermia","volume":"14","author":"Shchepotin","year":"1994","journal-title":"Anticancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/02656739709023553","article-title":"Apoptosis induced by hyperthermia and verapamil in vitro in a human colon cancer cell line","volume":"13","author":"Shchepotin","year":"1997","journal-title":"Int. J. Hyperth."},{"key":"ref_125","first-page":"13","article-title":"Effects of Verapamil on Bone Cancer Cells in vitro","volume":"3","author":"Fernandes","year":"2016","journal-title":"J. Cell Biol. Cell Metab."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Zeng, S., P\u00f6ttler, M., Lan, B., Gr\u00fctzmann, R., Pilarsky, C., and Yang, H. (2019). Chemoresistance in Pancreatic Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184504"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1073\/pnas.1818210116","article-title":"Cancer stemness, intratumoral heterogeneity, and immune response across cancers","volume":"116","author":"Miranda","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"111285","DOI":"10.1016\/j.biopha.2021.111285","article-title":"5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition","volume":"137","author":"Sethy","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7150\/ijbs.10248","article-title":"5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells","volume":"11","author":"Xu","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3892\/ijo.2016.3512","article-title":"Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells","volume":"49","author":"Zhao","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e4976","DOI":"10.1002\/bmc.4976","article-title":"Metabolomics analysis of multidrug resistance in colorectal cancer cell and multidrug resistance reversal effect of verapamil","volume":"35","author":"Wang","year":"2021","journal-title":"Biomed. Chromatogr."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Pacheco, M.B., Camilo, V., Lopes, N., Moreira-Silva, F., Correia, M.P., Henrique, R., and Jer\u00f3nimo, C. (2021). Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines. Pharmaceuticals, 14.","DOI":"10.3390\/ph14070670"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"21875","DOI":"10.18632\/oncotarget.7871","article-title":"The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells","volume":"7","author":"Lucendo","year":"2016","journal-title":"Oncotarget"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Lopes, N., Pacheco, M.B., Soares-Fernandes, D., Correia, M.P., Camilo, V., Henrique, R., and Jer\u00f3nimo, C. (2021). Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080976"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1038\/s41598-021-94323-0","article-title":"Hydralazine augmented ultrasound hyperthermia for the treatment of hepatocellular carcinoma","volume":"11","author":"Karmacharya","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fphar.2020.00577","article-title":"Repurposing Kir6\/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers","volume":"11","author":"Hegel","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10585-022-10166-7","article-title":"Anti-invasive effects of minoxidil on human breast cancer cells: Combination with ranolazine","volume":"39","author":"Qiu","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_138","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/01.ju.0000081126.71235.e0","article-title":"Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate","volume":"170","author":"Frederiksen","year":"2003","journal-title":"J. Urol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1182\/blood.V93.7.2342","article-title":"Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release","volume":"93","author":"Ushmorov","year":"1999","journal-title":"Blood"},{"key":"ref_141","first-page":"24","article-title":"Nitric oxide (NO) enhances pemetrexed cytotoxicity via NO-cGMP signaling in lung adenocarcinoma cells in vitro and in vivo","volume":"41","author":"Nagai","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/toxres\/tfac013","article-title":"Nitroglycerin-induced downregulation of AKT- and ERK1\/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cells","volume":"11","author":"Ko","year":"2022","journal-title":"Toxicol. Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.3892\/mmr.2015.3963","article-title":"Synergistic apoptosis-inducing effect of aspirin and isosorbide mononitrate on human colon cancer cells","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1476-5381.1995.tb16670.x","article-title":"Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate","volume":"116","author":"Papageorgiou","year":"1995","journal-title":"Br. J. Pharm."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12951-022-01676-3","article-title":"Synergetic delivery of artesunate and isosorbide 5-mononitrate with reduction-sensitive polymer nanoparticles for ovarian cancer chemotherapy","volume":"20","author":"Li","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.intimp.2013.06.021","article-title":"Sodium nitroprusside (SNP) sensitizes human gastric cancer cells to TRAIL-induced apoptosis","volume":"17","author":"Yang","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1137::AID-CNCR19>3.0.CO;2-7","article-title":"Differential induction of cell death in human glioma cell lines by sodium nitroprusside","volume":"82","author":"Blackburn","year":"1998","journal-title":"Cancer"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Ma, S.C., Zhang, J.Q., Yan, T.H., Miao, M.X., Cao, Y.M., Cao, Y.B., Zhang, L.C., and Li, L. (2023). Novel strategies to reverse chemoresistance in colorectal cancer. Cancer Med., 1\u201324.","DOI":"10.1002\/cam4.5594"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.HYP.17.4.589","article-title":"History of the design of captopril and related inhibitors of angiotensin converting enzyme","volume":"17","author":"Cushman","year":"1991","journal-title":"Hypertension"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/j.1552-4604.1995.tb04070.x","article-title":"The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension","volume":"35","author":"Burris","year":"1995","journal-title":"J. Clin. Pharmacol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.amjmed.2008.05.017","article-title":"Management of hypertension in patients with cardiac disease: Use of renin-angiotensin blocking agents","volume":"121","author":"Prisant","year":"2008","journal-title":"Am. J. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2165\/00003495-199142010-00006","article-title":"Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders","volume":"42","author":"Todd","year":"1991","journal-title":"Drugs"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1517\/14656566.2011.585460","article-title":"Perindopril for the treatment of hypertension","volume":"12","author":"Ghiadoni","year":"2011","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_155","first-page":"659","article-title":"Vascular permeability factor\/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia","volume":"77","author":"Denhart","year":"1997","journal-title":"Lab. Investig."},{"key":"ref_156","first-page":"1073","article-title":"The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: Possible role of the vascular endothelial growth factor","volume":"7","author":"Yoshiji","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00432-004-0582-7","article-title":"Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells","volume":"130","author":"Yasumatsu","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jsps.2022.06.019","article-title":"Perindopril sensitizes hepatocellular carcinoma to chemotherapy: A possible role of leptin\/Wnt\/\u03b2-catenin axis with subsequent inhibition of liver cancer stem cells","volume":"30","author":"Zakaria","year":"2022","journal-title":"Saudi Pharm. J."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/vhrm.2006.2.2.117","article-title":"A Review of Perindopril in the Reduction of Cardiovascular Events","volume":"2","author":"Campbell","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1751-7176.2010.00425.x","article-title":"The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure","volume":"13","author":"Bakris","year":"2011","journal-title":"J. Clin. Hypertens."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.clinthera.2011.10.007","article-title":"Azilsartan medoxomil: A new Angiotensin receptor blocker","volume":"33","author":"Zaiken","year":"2011","journal-title":"Clin. Ther."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.bmc.2013.02.061","article-title":"Synthetic approaches to the 2011 new drugs","volume":"21","author":"Ding","year":"2013","journal-title":"Bioorganic Amp. Med. Chem."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/00003495-199856050-00013","article-title":"Candesartan cilexetil. A review of its use in essential hypertension","volume":"56","author":"McClellan","year":"1998","journal-title":"Drugs"},{"key":"ref_164","first-page":"S9","article-title":"Candesartan cilexetil: A review of its preclinical pharmacology","volume":"11","author":"Nishikawa","year":"1997","journal-title":"J. Hum. Hypertens."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"ref_166","unstructured":"Bulsara, K.G., and Makaryus, A.N. (2018). Candesartan, StatPearls Publishing."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Jia, S., Qu, T., Wang, X., Feng, M., Yang, Y., Feng, X., Ma, R., Li, W., Hu, Y., and Feng, Y. (2017). KIAA1199 promotes migration and invasion by Wnt\/\u03b2-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175058"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15420\/usc.2010.7.2.25","article-title":"A Review of the Antihypertensive and Renal-protective Effects of Irbesartan","volume":"7","author":"Ferdinand","year":"2010","journal-title":"US Cardiol."},{"key":"ref_169","first-page":"22","article-title":"Irbesartan: Review of pharmacology and comparative properties","volume":"7","author":"Adams","year":"2000","journal-title":"Can. J. Clin. Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3111\/13696990701792355","article-title":"Losartan: A pharmacoeconomic review","volume":"10","author":"Carides","year":"2007","journal-title":"J. Med. Econ."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1470320309342735","article-title":"Efficacy in angiotensin receptor blockade: A comparative review of data with olmesartan","volume":"10","author":"Redon","year":"2009","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3109\/15376516.2015.1053647","article-title":"Synergistic, cytotoxic and apoptotic activities of olmesartan with NF-\u03baB inhibitor against HeLa human cell line","volume":"25","author":"Bakhtiari","year":"2015","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/00003495-200666010-00004","article-title":"Telmisartan: A review of its use in the management of hypertension","volume":"66","author":"Battershill","year":"2006","journal-title":"Drugs"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fnins.2020.00902","article-title":"Telmisartan, an Antagonist of Angiotensin II Receptors, Accentuates Voltage-Gated Na+ Currents and Hippocampal Neuronal Excitability","volume":"14","author":"Lai","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_175","first-page":"295","article-title":"Telmisartan is a potent target for prevention and treatment in human prostate cancer","volume":"20","author":"Funao","year":"2008","journal-title":"Oncol. Rep."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s002280050259","article-title":"Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man","volume":"52","author":"Flesch","year":"1997","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e000473","DOI":"10.1136\/openhrt-2016-000473","article-title":"Amlodipine in hypertension: A first-line agent with efficacy for improving blood pressure and patient outcomes","volume":"3","author":"Fares","year":"2016","journal-title":"Open Heart"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/10641960802580190","article-title":"Nicardipine: A hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile","volume":"30","author":"Amenta","year":"2008","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/106002809102501109","article-title":"Felodipine: A new dihydropyridine calcium-channel antagonist","volume":"25","author":"Yedinak","year":"1991","journal-title":"DICP"},{"key":"ref_180","unstructured":"Talreja, O., and Cassagnol, M. (2022). Diltiazem, StatPearls Publishing."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"118518","DOI":"10.1016\/j.lfs.2020.118518","article-title":"Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein","volume":"262","author":"Kandil","year":"2020","journal-title":"Life Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00003495-197815030-00001","article-title":"Verapamil: A review of its pharmacological properties and therapeutic use","volume":"15","author":"Singh","year":"1978","journal-title":"Drugs"},{"key":"ref_183","first-page":"129","article-title":"Verapamil in cardiac arrhythmias: An overview","volume":"6","author":"Vohra","year":"1982","journal-title":"Clin. Exp. Pharmacol. Physiol. Suppl."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1152\/japplphysiol.00238.2010","article-title":"Epigenetic alterations in aging","volume":"109","author":"Gonzalo","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-4-10","article-title":"Hydralazine target: From blood vessels to the epigenome","volume":"4","author":"Arce","year":"2006","journal-title":"J. Transl. Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/art.10833","article-title":"Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling","volume":"48","author":"Deng","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1080\/09546634.2021.1945527","article-title":"Minoxidil: A comprehensive review","volume":"33","author":"Gupta","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/sj.bjp.0705613","article-title":"Minoxidil opens mitochondrial K(ATP) channels and confers cardioprotection","volume":"141","author":"Sato","year":"2004","journal-title":"Br. J. Pharm."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.jacc.2017.09.1064","article-title":"The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics","volume":"70","author":"Divakaran","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_190","first-page":"1893","article-title":"The effect of antibody to L-phenylalanine mustard conjugate on malignant cells selectively marked through \"early inflammatory-like\" vascular permeability","volume":"26","author":"Burke","year":"1966","journal-title":"Cancer Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/bjc.1994.363","article-title":"Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma","volume":"70","author":"Seymour","year":"1994","journal-title":"Br. J. Cancer"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/gast.2002.34310","article-title":"Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells","volume":"123","author":"Millet","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000503688","article-title":"Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells","volume":"105","author":"Ko","year":"2020","journal-title":"Pharmacology"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejphar.2010.04.063","article-title":"Effects of isosorbide mononitrate on the restoration of injured artery in mice in vivo","volume":"640","author":"Chen","year":"2010","journal-title":"Eur. J. Pharm."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jash.2010.10.004","article-title":"Single-dose effects of isosorbide mononitrate alone or in combination with losartan on central blood pressure","volume":"4","author":"Kaufman","year":"2010","journal-title":"J. Am. Soc. Hypertens."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1126\/science.8102010","article-title":"Metal compounds in therapy and diagnosis","volume":"261","author":"Abrams","year":"1993","journal-title":"Science"},{"key":"ref_197","first-page":"47","article-title":"Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction","volume":"8","author":"Boolell","year":"1996","journal-title":"Int. J. Impot. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_199","first-page":"3055","article-title":"Increased gene expression of the ABCC5 transporter without distinct changes in the expression of PDE5 in human cervical cancer cells during growth","volume":"32","author":"Eggen","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/jcb.24147","article-title":"PDE5 inhibitor promotes melanin synthesis through the PKG pathway in B16 melanoma cells","volume":"113","author":"Zhang","year":"2012","journal-title":"J. Cell Biochem."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.arcmed.2012.08.006","article-title":"Evaluation of PDE5 and PDE9 expression in benign and malignant breast tumors","volume":"43","author":"Moeinifard","year":"2012","journal-title":"Arch. Med. Res."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/156802607779941198","article-title":"The novel functions of cGMP-specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary\/cardiovascular vessels","volume":"7","author":"Zhu","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.canlet.2015.10.024","article-title":"The cyclic GMP\/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma","volume":"370","author":"Tuttle","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2147\/TCRM.S188761","article-title":"Use of levosimendan in acute and advanced heart failure: Short review on available real-world data","volume":"15","author":"Pashkovetsky","year":"2019","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2147\/DDDT.S295214","article-title":"Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap","volume":"15","author":"Conti","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","article-title":"Current Cancer Epidemiology","volume":"9","author":"Mattiuzzi","year":"2019","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"145906","DOI":"10.1016\/j.gene.2021.145906","article-title":"Futuristic approach to cancer treatment","volume":"805","author":"Malik","year":"2021","journal-title":"Gene"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00120-017-0338-z","article-title":"Side effects of chemotherapy","volume":"56","author":"Hauner","year":"2017","journal-title":"Urol. A"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.21873\/anticanres.13639","article-title":"Renin\u2013Angiotensin Inhibition in Combating Malignancy: A Review","volume":"39","author":"ROSENTHAL","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/bs.acr.2020.05.003","article-title":"Ca2+ as a therapeutic target in cancer","volume":"148","author":"Gross","year":"2020","journal-title":"Adv. Cancer Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1021\/acs.jmedchem.6b01672","article-title":"Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects","volume":"60","author":"Huang","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1158\/1078-0432.CCR-15-1900","article-title":"Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy","volume":"22","author":"Catalano","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_215","first-page":"3961","article-title":"Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis","volume":"61","author":"Piazza","year":"2001","journal-title":"Cancer Res."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1200\/JCO.2003.02.114","article-title":"Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer","volume":"21","author":"Pusztai","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_217","first-page":"479","article-title":"Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival","volume":"2","author":"Whitehead","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"99179","DOI":"10.18632\/oncotarget.21837","article-title":"Phosphodiesterase type 5 and cancers: Progress and challenges","volume":"8","author":"Barone","year":"2017","journal-title":"Oncotarget"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic drug combinations tend to improve therapeutically relevant selectivity","volume":"27","author":"Krueger","year":"2009","journal-title":"Nat. Biotechnol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/4\/671\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:37:08Z","timestamp":1760121428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/4\/671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":219,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["cells12040671"],"URL":"https:\/\/doi.org\/10.3390\/cells12040671","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]}}}